FairJourney Biologics enters antibody discovery agreement with Pandion Therapeutics using novel discovery platforms
Diverse panel of novel target binders from FairJourney Biologics and IONTAS will be used to uncover functional antibodies to advance autoimmune and inflammatory disease research